Several African nations have recently refused U.S. aid packages that require the sharing of health data and biological specimens, citing concerns over patient privacy, national sovereignty, and a lack of reciprocal data protection. The Trump administration has characterized these deals as transactional, offering financial aid for access to data, a shift from previous, more diplomatically framed health initiatives.
Ghana, for instance, objected to the scope and breadth of data requested in a proposed deal. Arnold Kavaarpuo, executive director of Ghana's Data Protection Commission, stated that the government had concerns about generating data and transferring it to U.S. authorities without adequate measures to protect Ghanaian data and sovereignty. "Once the data left the Ghanaian borders, we had no control over what becomes of it," Kavaarpuo told the BBC.
Similarly, Zimbabwe rejected a deal due to concerns about requests for medical data, reportedly intended for sharing with U.S. pharmaceutical companies. A government spokesperson indicated that there were no guarantees that drugs or vaccines developed from any collected pathogens would be accessible to Zimbabweans, noting that the World Health Organization already provides a framework for data sharing and benefit sharing.
These rejections mark a departure from established health cooperation programs like USAID and PEPFAR, the U.S. President's Emergency Plan for AIDS Relief, through which African countries have historically shared medical information. The U.S. State Department maintains that the requested material is aggregated and de-identified data, consistent with what has been used for years in combating infectious diseases. However, experts suggest the nature of these new agreements has shifted.
Nelson Aghogho Evaborhene, a PhD fellow in global health governance at Roskilde University, described the change as moving from a politically tolerable, albeit unequal, relationship to a more "transactional leverage." He noted that past deals could be framed domestically as altruistic efforts to improve health services, a narrative that is now more difficult to sustain.
The lessons learned during the COVID-19 pandemic, particularly the race for vaccines and subsequent difficulties in securing doses, have also influenced African nations' perspectives. Aggrey Aluso, executive director of Resilience Action Network Africa (Rana), views Africa's valuable health information as a significant opportunity to contribute to global health security.
Rana, along with over 50 other civil society groups, has warned African leaders that the terms of these U.S. agreements do not align with African national or regional interests. This sentiment is echoed by South Africa's Health Minister, Dr. Aaron Motsoaledi, who stated that no self-respecting nation should agree to terms where the U.S. receives pathogen data and genomic sequencing in exchange for only five years of funding.
The heightened debate around health diplomacy comes amid recent outbreaks, such as the spread of Ebola in the Democratic Republic of Congo, underscoring the critical importance of preparedness and equitable partnerships in global health security.